{'fraction_non_alphanumeric': 0.022179363548698167, 'fraction_numerical': 0.0, 'mean_word_length': 5.611464968152866, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Electrochemotherapy with a Reduced Dose of Bleomycin in the Treatment of Advanced Skin Cancer. A Case Study

Squamous cutaneous skin cancer is common cancer with increasing incidence. Commonly is treated with surgery or radiotherapy, but a new technique has been emerging in recent years. Electrochemo-therapy (ECT) is innovative and still developing treatment of malignant tumors, especially effective in treating cutaneous malignancy. Its feasibility and efficacy have been proven in elderly patients with comorbidities who cannot undergo standard treatments. Some recent studies have focused on reducing bleomycin dose in elderly patients to minimalize side effects and concurrently obtain the same treatment outcome. This article presents a case study of an elder patient with advanced skin cancer, treated with electrochemotherapy with a reduced bleomycin dose, where a complete re-sponse was observed in a long-term follow-up period. Keywords: Electrochemotherapy; Bleomycin; Reduced dose; Squamous cell carcinoma; Elderly pa-tient